Product
Supplier
Encyclopedia
Inquiry
Flibaserin female commerial in stock buy - large image1
Flibaserin female commerial in stock buy - image1
Flibaserin female commerial in stock buy - image2
Flibaserin female commerial in stock buy - image3

Flibaserin female commerial in stock

11 Inquiries

Unit Price:

$5-6/KG FOB

Get Latest Price
CAS No.:

167933-07-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shanghai

Packaging:

Drum or Bag

Price valid (until):

2028-08-01

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

PEG,Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Product Name: Flibaserin

    CAS:167933-07-5
    MF:C20H21F3N4O
    MW:390.4

    Shop Flibaserin female commerial in stock-Detailed Image 1

                                                ------------------- Company Profile ------------------

    VITALGEN PHARMA CO., LIMITED is devoted to researching, manufacturing and marketing medical raw materials. The company has established a multi-functional R&D center in Shenzhen Zhongcheng Biomedical Industrial Park, which has a group of innovativedrugs and generic drugs technicians and 60 foreign trade professionals.


    VITALGEN PHARMA CO., LIMITEDcompany has built 500 square meters of pilot laboratories, equipped with two sets of 50L glass reactor, four sets of 100L double reactor, six sets of 50L rotary evaporator and matching heating and cooling equipment, to complete the 10kg Pilot complex experiments in complex compounds, a steady cooperation of the amplification plant, from 100kg to the tonnage of the enlarged production.


      medicine has been highly recognized by many well-known enterprises in the industry and has become their main supplier with high-quality products, honest and pragmatic attitude and good customer service. Tianyuan Medicine is dedicated to provide customers both at home and abroad with advanced technology and reasonable price , Quality products and professional technical services.

    Shop Flibaserin female commerial in stock-Detailed Image 2

    Shop Flibaserin female commerial in stock-Detailed Image 3

    Shop Flibaserin female commerial in stock-Detailed Image 4

    Basic Info
    Product Name:

    Flibanserin

    Other Name:

    2H-Benzimidazol-2-one,1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-;1,3-Dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-2H-benzimidazol-2-one;BIMT 17;Flibanserin;BIMT 17BS;Addyi;1-(2-[4-[3-(Trifluoromethyl)phenyl]piperazin-1-yl]ethyl)-1,3-dihydro-2H-benzimidazol-2-one

    CAS No.:

    167933-07-5

    Molecular Formula:

    C20H21F3N4O

    InChIKeys:

    InChIKey=PPRRDFIXUUSXRA-UHFFFAOYSA-N

    Molecular Weight:

    390.4

    Exact Mass:

    390.40

    EC Number:

    1806241-263-5

    Characteristics
    PSA:

    38.8

    XLogP3:

    3.3

    Appearance:

    white to beige

    Density:

    1.292 g/cm3

    Refractive Index:

    1.566

    Water Solubility:

    DMSO: soluble10mg/mL, clear

    Storage Conditions:

    2-8°C

    Vapor Pressure:

    3.13X10-10 mm Hg at 25 deg C (est)

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 3, Oral

    Skin irritation, Category 2

    Eye irritation, Category 2

    Specific target organ toxicity – single exposure, Category 3

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H301 Toxic if swallowed

    H315 Causes skin irritation

    H319 Causes serious eye irritation

    H335 May cause respiratory irritation

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P261 Avoid breathing dust/fume/gas/mist/vapours/spray.

    P271 Use only outdoors or in a well-ventilated area.

    Response

    P301+P316 IF SWALLOWED: Get emergency medical help immediately.

    P321 Specific treatment (see ... on this label).

    P330 Rinse mouth.

    P302+P352 IF ON SKIN: Wash with plenty of water/...

    P332+P317 If skin irritation occurs: Get medical help.

    P362+P364 Take off contaminated clothing and wash it before reuse.

    P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

    P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

    P319 Get medical help if you feel unwell.

    Storage

    P405 Store locked up.

    P403+P233 Store in a well-ventilated place. Keep container tightly closed.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    PEG,Semaglutide

    Location:

    1003 SHINGIND BLDG 42-46 TAI LIN PAI RD KWAI CHUNG HONGKONG

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A

    Average lead Time:

    350

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2018

     VITALGEN PHARMA CO., LIMITED is an international leading high-tech enterprise focusing on large-scale biosynthesis of polypeptide drugs. We provide all-round products and services from drug research, clinical development to access to market for global biotechnology and pharmaceutical enterprises.

    We have professional and experienced engineers and scientists, providing new polypeptide drug biosynthesis solutions, which help partners stay ahead of the polypeptide drug discovery, clinical development and market production.
    We have more than 5000 square meters of R&D center and 20000 square meters of intelligent manufacturing base, which can meet the needs of different customers and products, while meeting the GMP conditions for drug production

  • Inquiry History
    11 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Flibanserin for for Women CAS 167933-07-5

    5 G Apr 29, 2026
    United States

    Flibanserin

    10 G Nov 28, 2024
    United States

    Flibanserin

    3000 MG Aug 23, 2024
    Malaysia

    Flibanserin

    100 G Jul 18, 2024
    United Kingdom

    Flibanserin for Female Sex Enhancement

    10 G Feb 6, 2026
    United States

    Flibanserin 99%

    1 KG Feb 2, 2026
    Nigeria

    flibanserin

    50 KG Nov 14, 2025
    Madagascar

    Flibanserin

    60 G Oct 21, 2024
    Mexico

    Flibanserin 100mg tablets/pills

    100 G Aug 10, 2024
    Mexico

    Flibanserin 100mg tablets/pills

    100 G Aug 10, 2024
    Estonia

    Flibanserin

    10 G Feb 26, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.